Recombinant Anti-CD64 x Anti-malaria antigen Bispecific Antibody (Minibody) is designed to be expressed as the anti-CD64 scFv fused to N-terminus of Knob-CH3 domain and the anti-malaria antigen scFv to the Hole-CH3 domain, or vice versa. The CH3 domains are further stabilized by C-terminal disulfide bonds. This BsAb can retarget NK cells to genus plasmodium. It is designed for the research of Malaria therapy.
There are currently no customer reviews or questions for Recombinant Human Anti-CD64 x Human Anti-malaria antigen Bispecific Antibody (Minibody) (MiniB-H303). Click the button below to contact us or submit your feedback about this product.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRYSERVICES
PRODUCTS
PLATFORMS